Using AI and blockchain to speed up drug discovery
Chemical instruments-aware distributed blockchain based open AI platform to accelerate drug discovery
This study is looking at how to make discovering new medicines faster and easier by using smart technology to help scientists share important information safely, so patients can get new treatments more quickly.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Purdue University NIH-funded |
| Lab location | 1 site (West Lafayette, United States) |
| Project ID | NIH-10665719 on NIH RePORTER |
What this research studies
This research aims to enhance the drug discovery process by integrating artificial intelligence (AI) and blockchain technology. It addresses the challenges faced by medicinal chemists, such as the lengthy timelines and difficulties in sharing critical data due to intellectual property concerns. By creating a decentralized platform that allows for better data sharing and collaboration among laboratories, the project seeks to streamline the design-make-test-analyze cycle in drug development. Patients may benefit from faster access to innovative treatments as a result of this improved process.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with conditions that currently lack effective treatments or those who are waiting for new drug developments.
Not a fit: Patients with conditions that are already well-managed by existing therapies may not see direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the time it takes to bring new drugs to market, providing patients with quicker access to effective therapies.
How similar studies have performed: While the integration of AI and blockchain in drug discovery is a novel approach, similar initiatives have shown promise in improving data sharing and collaboration in other fields.
Where this research is happening
West Lafayette, United States
- Purdue University — West Lafayette, United States (Active)
Researchers
- Principal investigator: Chopra, Gaurav — Purdue University
- Study coordinator: Chopra, Gaurav
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.